CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in Deutsche Bank 39th Annual Health Care Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Wednesday, May 7, 2014 at 3:30 p.m. ET.
Aegerion will also participate in the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas. Mr. Beer is scheduled to present on Thursday, May 15, 2014 at 12:00 p.m. PT (3:00 p.m. ET).
Both presentations will be webcast live, and may be accessed for up to 30 days following the conference by visiting the "Investors" section of Aegerion's website, www.aegerion.com.
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.